Health and Healthcare

MannKind : MNKD

All MannKind Articles

305 Articles

Chris Lange | Jan 13, 2020 at 8:40 AM EST

Major Biotechs Have Short Sellers Excited

The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech…

Chris Lange | Dec 26, 2019 at 8:40 AM EST

Major Biotechs See Rising Short Interest

The December 13 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Dec 11, 2019 at 9:10 AM EST

Major Biotechs See a Rising Tide in Short Interest

The November 29 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Nov 27, 2019 at 8:40 AM EST

Short Sellers Run For Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The November 15 short interest data…

Chris Lange | Nov 12, 2019 at 10:00 AM EST

Major Biotechs See Rising Tide in Short Interest

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data…

Chris Lange | Oct 25, 2019 at 10:05 AM EDT

Major Biotechs See Rising Tide in Short Interest

The October 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Oct 10, 2019 at 10:00 AM EDT

Short Sellers Hike Bets in Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 30 short interest data…

Chris Lange | Sep 25, 2019 at 9:30 AM EDT

Major Biotechs Scare Off Short Sellers

The September 13 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 12, 2019 at 8:40 AM EDT

Major Biotechs Scare Off Short Sellers

The August 30 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Aug 27, 2019 at 9:15 AM EDT

Short Sellers Hike Their Bets in Biotech

The August 15 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Aug 12, 2019 at 10:55 AM EDT

8 Biotechs Being Choked by Short Sellers

Short sellers seem to have many emerging and speculative biotech stocks targeted for termination. Here are eight of them against…

Chris Lange | Aug 12, 2019 at 8:50 AM EDT

Short Sellers Make a Move on Big Biotechs

The July 31 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jul 25, 2019 at 8:40 AM EDT

Major Biotechs See Rising Tide in Short Interest

The July 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jul 11, 2019 at 9:50 AM EDT

Short Sellers Run for Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data…

Chris Lange | Jun 26, 2019 at 10:05 AM EDT

Big Biotechs Scare Off Short Sellers

The June 14 short interest data has been compared with the previous report, and short interest in most of these…

1 2 3 4 … 21

MannKind : MNKD

All MannKind Articles

Major Biotechs Have Short Sellers Excited

Major Biotechs See Rising Short Interest

Major Biotechs See a Rising Tide in Short Interest

Short Sellers Run For Cover From Major Biotechs

Major Biotechs See Rising Tide in Short Interest

Major Biotechs See Rising Tide in Short Interest

Short Sellers Hike Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

Major Biotechs Scare Off Short Sellers

Short Sellers Hike Their Bets in Biotech

8 Biotechs Being Choked by Short Sellers

Short Sellers Make a Move on Big Biotechs

Major Biotechs See Rising Tide in Short Interest

Short Sellers Run for Cover From Major Biotechs

Big Biotechs Scare Off Short Sellers

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

MannKind : MNKD

All MannKind Articles

Major Biotechs Have Short Sellers Excited

Major Biotechs See Rising Short Interest

Major Biotechs See a Rising Tide in Short Interest

Short Sellers Run For Cover From Major Biotechs

Major Biotechs See Rising Tide in Short Interest

Major Biotechs See Rising Tide in Short Interest

Short Sellers Hike Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

Major Biotechs Scare Off Short Sellers

Short Sellers Hike Their Bets in Biotech

8 Biotechs Being Choked by Short Sellers

Short Sellers Make a Move on Big Biotechs

Major Biotechs See Rising Tide in Short Interest

Short Sellers Run for Cover From Major Biotechs

Big Biotechs Scare Off Short Sellers

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not